Kaleb Tesfai
YOU?
Author Swipe
View article: Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non‐Lean Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease—Authors' Reply
Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non‐Lean Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease—Authors' Reply Open
View article: Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease Open
Objectives Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease globally, with an estimated prevalence exceeding 25%. Variants in the PNPLA3 and HSD17B13 genes have been a focus of investigations surroundi…
View article: Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes Open
Background and Aims: Recently, the American Gastroenterological Association and the American Association for the Study of Liver Diseases developed clinical pathways to evaluate populations at high risk for NAFLD. We assessed the diagnostic…
View article: Contents
Contents Open
View article: JHEP at a glance (March 2023)
JHEP at a glance (March 2023) Open
Prevalence (%) Advanced fibrosis 10 12 14 16 18 8 6 4 2 0 20 Obese (n = 281) Non-obese (n = 209) Prevalence (%) Among 29 participants with cirrhosis, 2 had HCC and 1 had gallbladder adenocarcinoma 5.9% n = 29 14.0% n = 69 65.3% n = 322 NAF…
View article: A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes Open